HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 84 filers reported holding HUMACYTE INC in Q3 2023. The put-call ratio across all filers is 63.87 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $229,433 | -13.4% | 78,305 | -15.5% | 0.00% | – |
| Q2 2023 | $265,037 | +13.4% | 92,670 | +22.5% | 0.00% | – |
| Q1 2023 | $233,743 | +125.8% | 75,645 | +54.2% | 0.00% | – |
| Q4 2022 | $103,514 | -32.3% | 49,059 | +4.5% | 0.00% | – |
| Q3 2022 | $153,000 | +18.6% | 46,968 | +17.0% | 0.00% | – |
| Q2 2022 | $129,000 | -57.0% | 40,143 | -5.8% | 0.00% | – |
| Q1 2022 | $300,000 | -55.0% | 42,603 | -53.6% | 0.00% | – |
| Q4 2021 | $666,000 | -20.7% | 91,817 | +26.9% | 0.00% | – |
| Q3 2021 | $840,000 | – | 72,343 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| York Capital Management Global Advisors, LLC | 2,291,397 | $16,177,000 | 4.71% |
| Endowment Wealth Management, Inc. | 96,618 | $682,000 | 0.72% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 36,171 | $255,000 | 0.24% |
| Prescott General Partners LLC | 625,100 | $4,413,000 | 0.20% |
| CenterBook Partners LP | 45,752 | $323,000 | 0.12% |
| Gladstone Institutional Advisory LLC | 144,867 | $1,023 | 0.07% |
| Exos Asset Management LLC | 18,609 | $131,000 | 0.06% |
| Sciencast Management LP | 26,300 | $182,000 | 0.04% |
| Y-Intercept (Hong Kong) Ltd | 17,125 | $121,000 | 0.03% |
| Kovack Advisors, Inc. | 31,500 | $222,000 | 0.02% |